AAOMS Annual Meeting

Conference Coverage

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA
FDA
FDA Approves First US Treatment for Chagas Disease
08/30/2017
After clinical trials demonstrated its efficacy and safety, a new treatment option for children with Chagas disease has been approved by the US Food and Drug Administration.
08/30/2017
FDA
FDA
FDA Approves First US Treatment for Chagas Disease
08/30/2017
After clinical trials demonstrated its efficacy and safety, a new treatment option for children with Chagas disease has been approved by the US Food and Drug Administration.
08/30/2017
Rheumatologic disorders
Rheumatologic disorders
FDA Approves Biosimilar to Humira
08/28/2017
The US Food and Drug Administration recently approved a biosimilar to Humira for the treatment of multiple inflammatory diseases in adult patients.
08/28/2017
Rheumatologic disorders
Rheumatologic disorders
FDA Approves Biosimilar to Humira
08/28/2017
The US Food and Drug Administration recently approved a biosimilar to Humira for the treatment of multiple inflammatory diseases in adult patients.
08/28/2017
Rheumatologic disorders
Rheumatologic disorders
FDA Approves Biosimilar to Humira
08/28/2017
The US Food and Drug Administration recently approved a biosimilar to Humira for the treatment of multiple inflammatory diseases in adult patients.
08/28/2017
Diabetes Q&A
Diabetes Q&A
FDA Expands Indication for Victoza
08/28/2017
The US Food and Drug administration expanded the indication for Victoza, a GLP-1 analog originally approved in 2010.
08/28/2017
Diabetes Q&A
Diabetes Q&A
FDA Expands Indication for Victoza
08/28/2017
The US Food and Drug administration expanded the indication for Victoza, a GLP-1 analog originally approved in 2010.
08/28/2017
Diabetes Q&A
Diabetes Q&A
FDA Expands Indication for Victoza
08/28/2017
The US Food and Drug administration expanded the indication for Victoza, a GLP-1 analog originally approved in 2010.
08/28/2017
Breast cancer
Breast cancer
FDA Expands Approval of Faslodex
08/28/2017
The US Food and Drug Administration has expanded the approval of Faslodex, a hormonal therapy for the treatment of breast cancer first approved in 2002.
08/28/2017
Breast cancer
Breast cancer
FDA Expands Approval of Faslodex
08/28/2017
The US Food and Drug Administration has expanded the approval of Faslodex, a hormonal therapy for the treatment of breast cancer first approved in 2002.
08/28/2017